Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vaccine-associated enhanced disease in humans and animal models: Lessons and challenges for vaccine development
Julie Bigay, Roger Le Grand, Frédéric Martinon, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

COVID-19 mRNA Vaccines: Lessons Learned from the Registrational Trials and Global Vaccination Campaign
M. Nathaniel Mead, Stephanie Seneff, Russ Wolfinger, et al.
Cureus (2024)
Open Access | Times Cited: 13
Recommendation for the Use of Respiratory Syncytial Virus Vaccines
Ping‐Ing Lee, Yhu‐Chering Huang, Hsiao‐Sheng Liu, et al.
Journal of Microbiology Immunology and Infection (2025)
Open Access
Respiratory System
Molly H. Boyle, Jack R. Harkema, Kristen J. Nikula, et al.
Elsevier eBooks (2025), pp. 235-335
Closed Access
Importance, Applications and Features of Assays Measuring SARS-CoV-2 Neutralizing Antibodies
Pia Gattinger, Anna Ohradanova‐Repic, Rudolf Valenta
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5352-5352
Open Access | Times Cited: 19
Review and Update of Active and Passive Immunization Against Respiratory Syncytial Virus
Charl Verwey, Shabir A. Madhi
BioDrugs (2023) Vol. 37, Iss. 3, pp. 295-309
Open Access | Times Cited: 17
First Impressions Matter: Immune Imprinting and Antibody Cross-Reactivity in Influenza and SARS-CoV-2
Samantha M. King, Shane P. Bryan, Shannon P. Hilchey, et al.
Pathogens (2023) Vol. 12, Iss. 2, pp. 169-169
Open Access | Times Cited: 15
Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children: Rationale and Progress to Date
Charl Verwey, Ziyaad Dangor, Shabir A. Madhi
Pediatric Drugs (2023) Vol. 26, Iss. 2, pp. 101-112
Open Access | Times Cited: 15
COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 1
M. Nathaniel Mead, Stephanie Seneff, Russ Wolfinger, et al.
International Journal of Vaccine Theory Practice and Research (2024) Vol. 3, Iss. 2, pp. 1112-1178
Closed Access | Times Cited: 6
Vaccines Induce Homeostatic Immunity, Generating Several Secondary Benefits
Balasubramanian Arunachalam
Vaccines (2024) Vol. 12, Iss. 4, pp. 396-396
Open Access | Times Cited: 4
Adjuvant-dependent impact of inactivated SARS-CoV-2 vaccines during heterologous infection by a SARS-related coronavirus
Jacob A. Dillard, Sharon Taft-Benz, Audrey C. Knight, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Have Diagnostics, Therapies, and Vaccines Made the Difference in the Pandemic Evolution of COVID-19 in Comparison with “Spanish Flu”?
Florigio Lista, Mario Stefano Peragallo, Roberto Biselli, et al.
Pathogens (2023) Vol. 12, Iss. 7, pp. 868-868
Open Access | Times Cited: 8
Vaccination for Respiratory Syncytial Virus: A Narrative Review and Primer for Clinicians
Kay Choong See
Vaccines (2023) Vol. 11, Iss. 12, pp. 1809-1809
Open Access | Times Cited: 8
Influenza breakthrough infection in vaccinated mice is characterized by non-pathological lung eosinophilia
Lauren A. Chang, Angela Choi, Raveen Rathnasinghe, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Characterization and immunogenicity assessment of MERS-CoV pre-fusion spike trimeric oligomers as vaccine immunogen
Rahul Ahuja, Preeti Vishwakarma, Sneha Raj, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 2
Infection-Simulator, Immunostimulatory and Immunomodulatory Effects of Interferons I and III in Biological Systems: A New Era in Vaccinology and Therapeutics Possible?
Theodor-Nicolae Carp, Michael Metoudi, Vanshika Ojha
(2024)
Open Access | Times Cited: 2
Ally, adversary, or arbitrator? The context-dependent role of eosinophils in vaccination for respiratory viruses and subsequent breakthrough infections
Lauren A. Chang, Michael Schotsaert
Journal of Leukocyte Biology (2024)
Open Access | Times Cited: 1
Antibody Dependent Enhancement (ADE) of Infection into Macrophages Validates the Importance of HERV-K102 Particle Production for Pandemic Preparedness
Marian P. Laderoute
(2024)
Open Access | Times Cited: 1
Trends and insights in dengue virus research globally: a bibliometric analysis (1995–2023)
Yumeng Liu, Mengmeng Wang, Ning Yu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Safety and Immunogenicity Study of a Bivalent Vaccine for Combined Prophylaxis of COVID-19 and Influenza in Non-Human Primates
Ekaterina Stepanova, Irina Isakova-Sivak, Victoria Matyushenko, et al.
Vaccines (2024) Vol. 12, Iss. 10, pp. 1099-1099
Open Access | Times Cited: 1
The Impact of Vaccination on COVID-19, Influenza, and Respiratory Syncytial Virus-Related Outcomes: A Narrative Review
Roberto Debbag, Deborah Rudin, Francesca Ceddia, et al.
Infectious Diseases and Therapy (2024)
Open Access | Times Cited: 1
Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus Vaccine in Infants 6–7 Months of age: A Phase 1/2 Randomized Trial
Xavier Sáez‐Llorens, Ximena Norero, Marisa Márcia Mussi‐Pinhata, et al.
The Journal of Infectious Diseases (2023) Vol. 229, Iss. 1, pp. 95-107
Open Access | Times Cited: 4
Spontaneous Lethal Outbreak of Influenza A Virus Infection in Vaccinated Sows on Two Farms Suggesting the Occurrence of Vaccine-Associated Enhanced Respiratory Disease with Eosinophilic Lung Pathology
Wencke Reineking, Isabel Hennig‐Pauka, Ludger Schröder, et al.
Viruses (2024) Vol. 16, Iss. 6, pp. 955-955
Open Access
Impfungen gegen das Respiratorische Synzytial-Virus
Annika Glock, Micha Banz, Mathias W. Pletz
Deleted Journal (2024) Vol. 01, Iss. 04, pp. 315-332
Closed Access
Enterovirus Antibodies: Friends and Foes
Chaldam Jespère Mbani, Corentin Morvan, Magloire Pandoua Nekoua, et al.
Reviews in Medical Virology (2024) Vol. 34, Iss. 6
Open Access
Hamsters immunized with formalin-inactivated SARS- CoV-2 develop accelerated lung histopathological lesions and Th2-biased response following infection
Rineke de Jong, Sandra Vreman, Katrin E. Wiese, et al.
Research Square (Research Square) (2024)
Open Access
Page 1 - Next Page

Scroll to top